By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Foamix Pharmaceuticals, Ltd. 

2 Holzman Street
Weizmann-Science Park
Rehovot    76704  Israel
Phone: 972-8-9316233 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Foamix Pharmaceuticals, Ltd. (FOMX) To Host Conference Call & Webcast To Discuss Topline Results From Phase II Study Of FDX-104 In Acneiform Rash Associated With Targeted Antibody Treatments For Colon And Head And Neck Cancers 12/3/2015 7:20:37 AM
Shares Jump as Foamix Pharma (FOMX)'s FDX104 Shows Efficacy in Phase II Study 12/3/2015 6:04:07 AM
Foamix Pharmaceuticals, Ltd. (FOMX) To Present Corporate Overview At The Oppenheimer 26th Annual Healthcare Conference 12/1/2015 8:08:56 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Third Quarter 2015 Financial Results And Provides Business Update 11/11/2015 10:32:52 AM
Foamix Pharmaceuticals, Ltd. (FOMX) To Present Corporate Overview At Jefferies Autumn 2015 Global Healthcare Conference In London 11/11/2015 10:17:43 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Third Quarter 2015 Conference Call And Webcast Scheduled For Wednesday, November 11 10/28/2015 10:09:37 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Enrollment Of First Patient In Phase II Clinical Trial Of FMX103 In Papulopustular Rosacea 10/20/2015 7:26:24 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Second Quarter 2015 Financial Results And Provides Business Update 8/20/2015 8:11:20 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Second Quarter 2015 Conference Call & Webcast Scheduled For Thursday, August 20 8/13/2015 10:05:32 AM
Bayer HealthCare (BAY) and Foamix Pharmaceuticals, Ltd. (FOMX) Release: Finacea (Azelaic Acid) Foam 15%, Approved By U.S. FDA For Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea 7/31/2015 7:53:51 AM
123456
//-->